FDA urged to act swiftly to settle confusion in CBD market

“Time is of the essence.” The statement, made by Andrew Kline of the National Cannabis Industry Association (NCIA), encapsulates the views of many people who attended a recent public hearing hosted by FDA on cannabidiol (CBD) products. During the May 31 hearing in Silver Spring, Maryland, several speakers urged FDA to provide clarity to a…

Collagen: An ingredient for the ages

To be “beautiful inside and out” is the ultimate compliment. Imagine a supplement that performs its healthy aging functions internally as effectively it does externally, supporting both fluid movement and glowing, resilient skin. These flexible feats are among the boasts of collagen, a word derived from kolla, or “glue” in Greek. The collagen movement began…

Supply chain transparency: A practice of trust through legitimacy, from ‘farm to fork’

How important is supply chain transparency to supplement brands? The level of its importance determines the level of the business’ growth and success. Supply chain transparency builds trust through legitimacy across the board–trust with suppliers, employees, customers and oversight agencies. Are you transparent in the chain? Are others transparent with you? More importantly, how high…

FDA launches tool to ‘quickly alert’ consumers of unlawful ingredients marketed as supplements

FDA announced today a new tool designed to quickly alert consumers of ingredients unlawfully marketed as supplements. Dubbed the Dietary Supplement Ingredient Advisory List, the tool is intended to provide rapid notification to consumers of unlawful ingredients in order to better protect them from potentially dangerous ingredients. Included in the list are ingredients FDA deems not…

Ensuring supply chain integrity before beginning supplement operations

In this remarkable age of international supply chains, instant transmissions of electronic information and voice communications, and the varied impositions of tariffs by different governments, the need for supply “country of origin” transparency has never been greater. Recent statements from FDA Commissioner Scott Gottlieb, M.D., showed the agency believes it needs to step up its…